275 related articles for article (PubMed ID: 2560525)
1. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
Grose C
Mol Biol Med; 1989 Oct; 6(5):453-62. PubMed ID: 2560525
[TBL] [Abstract][Full Text] [Related]
2. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
[TBL] [Abstract][Full Text] [Related]
3. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
Berger R; Luescher D; Just M
Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
[TBL] [Abstract][Full Text] [Related]
4. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
[TBL] [Abstract][Full Text] [Related]
5. Molecular studies of Varicella zoster virus.
Quinlivan M; Breuer J
Rev Med Virol; 2006; 16(4):225-50. PubMed ID: 16791838
[TBL] [Abstract][Full Text] [Related]
6. Immune evasion as a pathogenic mechanism of varicella zoster virus.
Abendroth A; Arvin AM
Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
[TBL] [Abstract][Full Text] [Related]
7. Distribution of varicella-zoster virus DNA and gene products in tissues of a first-trimester varicella-infected fetus.
Nikkels AF; Delbecque K; Pierard GE; Wienkotter B; Schalasta G; Enders M
J Infect Dis; 2005 Feb; 191(4):540-5. PubMed ID: 15655777
[TBL] [Abstract][Full Text] [Related]
8. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
Welsh MD; Harper DR; Garcia-Valcarcel M; Fowler WJ; Aitken C; Jeffries DJ; Layton GT
J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
[TBL] [Abstract][Full Text] [Related]
9. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
Berger R; Luescher D; Just M; D'Hondt E; Bogaert H
Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
11. Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus.
Vossen MT; Gent MR; Weel JF; de Jong MD; van Lier RA; Kuijpers TW
J Infect Dis; 2004 Jul; 190(1):72-82. PubMed ID: 15195245
[TBL] [Abstract][Full Text] [Related]
12. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
[TBL] [Abstract][Full Text] [Related]
13. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
Breuer J; Schmid DS; Gershon AA
J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
[TBL] [Abstract][Full Text] [Related]
15. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection.
Chris Maple PA; Gray J; Brown K; Brown D
J Virol Methods; 2009 Apr; 157(1):90-2. PubMed ID: 19135089
[TBL] [Abstract][Full Text] [Related]
16. Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170.
Arvin AM; Kinney-Thomas E; Shriver K; Grose C; Koropchak CM; Scranton E; Wittek AE; Diaz PS
J Immunol; 1986 Aug; 137(4):1346-51. PubMed ID: 3016094
[TBL] [Abstract][Full Text] [Related]
17. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
Watson B
J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of varicella-zoster virus (VZV)-specific antibodies in the early phase of varicella in immunocompromized children.
Nyerges G; Mészner Z; Simon M
Acta Microbiol Hung; 1983; 30(3-4):211-5. PubMed ID: 6326459
[TBL] [Abstract][Full Text] [Related]
19. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
Chiba Y; Miura J; Kumagai T; Nakao T
Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
[TBL] [Abstract][Full Text] [Related]
20. Sequence analysis of the leftward end of simian varicella virus (EcoRI-I fragment) reveals the presence of an 8-bp repeat flanking the unique long segment and an 881-bp open-reading frame that is absent in the varicella zoster virus genome.
Mahalingam R; White T; Wellish M; Gilden DH; Soike K; Gray WL
Virology; 2000 Sep; 274(2):420-8. PubMed ID: 10964784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
